Canvas Medical Reels In $24 Million - Silicon Valley Daily

2022-07-20 21:04:03 By : Ms. Wendy Liu

Daily news about tech companies in Silicon Valley.

SAN FRANCISCO  — Canvas Medical, the EMR that enables clinicians and developers to power the future of care delivery, has raised $24 million in Series B funding led by M13 with participation from Haystack and previous investors Inspired Capital, IA Ventures, Upfront Ventures, and Irongrey. Canvas provides a full-stack ambulatory EMR and digital health developer platform, enabling both established and startup healthcare providers to launch new patient experiences and business models faster.

In addition to this funding, Canvas has achieved federal certification through the Office of the National Coordinator for Health Information Technology (ONC). The ONC certification represents a major product milestone for the company: Canvas is one of the first EMRs in the United States  to support a standardized patient data API as envisioned by the 21st Century Cures Act. Additionally, with this certification, Canvas customers are now eligible for value-based payment models in Medicare and Medicaid programs, as well as many commercial value-based programs.

Founded in 2015, Canvas is reimagining the EMR for the future of healthcare. Customers include care delivery companies like a mental health startup that uses Canvas to create custom clinical pathways, support telehealth scheduling and charting, and drive care team collaboration with their patient app); and a primary care provider for adults 65+ that uses Canvas to embed clinical workflows into the point of care and enables patients to communicate with providers through Canvas’s APIs. Canvas’s suite of products are highly customizable by developers, seamless for providers, and give care delivery companies full control over their patient experience.

“The healthcare industry is at an inflection point: software developers are now de facto members of the care team at leading care delivery companies. With new entrants coming to market daily and established players investing in innovation, Canvas is a best-in-class platform partner for the full spectrum of those building new models of care,” says Andrew Hines , Founder and CEO of Canvas Medical. “It is inspiring to see at each of our customer organizations how their clinicians and developers work together in Canvas to build and refine the best possible model of care for the patients they serve.”

“We are thrilled to lead the Series B in Canvas Medical,” says Latif Peracha  of M13. “Canvas serves digital-enabled care-delivery companies and fosters developer-caregiver collaboration to design and implement better care models for patients. Canvas is building the enabling infrastructure to power the entire digital health market, and we believe they will win by driving competition among services and applications that touch the end patient. Canvas’s ONC Certification is a significant milestone that sets Canvas apart from other modern EMRs and is a testament to the maturity of their product.”

“Canvas has enabled us to get our care delivery operations up and running much faster and with far less resourcing than we possibly could have done with any other EMR,” said Chris Hogg , founder and CEO of Marley Medical, a virtual primary care clinic. “As a provider to patients with complex chronic disease, including patients on Medicare, the Canvas team’s commitment to achieving ONC Certification was a critical part of our decision to work together.”

PALO ALTO –  AV8 Ventures has launched its second fund with $180 million backed by German financial services giant Allianz. AV8 is an early-stage investor that funds entrepreneurs who are commercializing emerging technologies in AI-driven health, mobility and enterprise. AV8 Ventures has invested in 20 companies with a focus on the US since its launch […]

SAN FRANCISCO  — Color, a health technology company committed to advancing public health, has secured a $100 million Series E financing round. This brings Color to $378 million in total financing, with a valuation of $4.6 billion. The round was led by Kindred Ventures and by certain funds and accounts advised by T. Rowe Price Associates, Inc. with participation […]

MOUNTAIN VIEW — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, has secured a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. The round was led by funds managed by Blackstone […]